Pancreatic beta cells maintain glucose homeostasis by secreting insulin following a rise in plasma glucose. Insulin secretion is pulsatile, which is brought about because of oscillations in the concentrations of beta-cell cytosolic Ca2+. The endoplasmic reticulum (ER) helps to regulate the cytosolic Ca2+ level, thereby playing a role in Ca2+-induced insulin release. ER stress, triggered by the accumulation of unfolded proteins in the ER, can lead to the ER Ca2+ depletion, which in turn can contribute to beta-cell deterioration and an increased risk of type-2 diabetes. We sought to determine the effects of tunicamycin (TM)-induced ER stress on ER Ca2+ channels, inositol 1,4,5-triphosphate (IP3) receptors (IP3Rs) and ryanodine receptors (RyRs), and subsequent alterations in beta-cell Ca2+ homeostasis that result from these alterations. To determine the roles of these receptors in TM-induced beta-cell dysfunction, we treated mouse pancreatic islets with the RyR1 inhibitor dantrolene (Dan) or the IP3R inhibitor xestospongin C (XeC) along with TM. Beta cells treated with TM exhibited altered cytosolic and mitochondrial Ca2+ when in sub-threshold glucose compared to vehicle controls. As TM treatment also reduced ER Ca2+, this raised the possibility that the mitochondrial and cytosolic Ca2+ oscillations seen in stressed cells resulted from increased ER Ca2+ efflux mediated by RyRs and/or IP3Rs. We found that TM-induced ER Ca2+ depletion, as well as cytosolic and mitochondrial Ca2+ oscillations were inhibited by co-treatment with Dan, whereas the inclusion of XeC had little or no effect. Taken together, these results suggest that RyRs, and more specifically RyR1 plays a critical role in mediating the disturbed cellular Ca2+ homeostasis seen in response to the induction of ER stress.

Disclosure

I. Zhang: None. V. S. Parekh: None. J. J. Leon: None. L. S. Satin: None.

Funding

National Institutes of Health (R01DK46409); University of Michigan; JDRF (2-SRA-2018-539-A-B)

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.